VRTX Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.

$183.59  -2.65 (-1.42%)
As of 11/26/2021 13:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/08/2001
Outstanding shares:  254,251,938
Average volume:  1,840,585
Market cap:   $47,351,880,933
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92532F100
ISIN:        US92532F1003
Sedol:      2931034

---

Valuation   (See tab for details)

---

PE ratio:   21.45
PB ratio:   4.94
PS ratio:   6.64
Return on equity:   22.83%
Net income %:   30.52%